UPDATE—Just learned that Eli Lilly executives are raging and furious at losing $20 billion in market cap from this stunt with @TwitterBlue. It’s too bad they don’t see their own damn insulin price gouging as the actual problem. Karma @LillyPad, karma.
Why would they see it as a problem? It’s always been about money, never about public health.
Nov 22, 2022 · 11:39 PM UTC